1. The age range of patients responding to the survey was 28-85 with a mean of 58\(\pm\)12 years with the duration of their disorder less than 5 years in 63% of cases.

2. Patients experience variable treatment, if at all, for post-viral olfactory loss

3. If treatment is given oral and/or intranasal steroids are typically given.

4. Several patients reported receiving imaging despite this not being clinically useful when there is a clear history and normal examination.

5. Over two thirds of patients experience parosmia and up to 5 years of the onset of the problem were still actively seeking a solution.